TrialBlood2015
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.
Michael A Pulsipher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
130 papers cite itlatest 60 shown
this paperpooled ittrialcites it